Jill Leversage Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

Jill Leversage is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 25,053 shares of AUPH, which is worth approximately $231,740. The most recent transaction as insider was on Nov 21, 2024, when has been sold 12,135 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.1K

93.94% 3M change

35.22% 12M change

Total Value Held $231,740

Jill Leversage Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2024	BUY Grant, award, or other acquisition	-	12,135 Added 32.63%	25,053 Common Shares
May 21 2024	SELL Open market or private sale	$32,201 $5.74 p/Share	5,610 Reduced 30.28%	12,918 Common Stock
May 23 2023	SELL Open market or private sale	$54,216 $11.26 p/Share	4,815 Reduced 20.63%	18,528 Common Stock
May 19 2023	BUY Grant, award, or other acquisition	-	9,310 Added 28.51%	23,343 Common Stock
May 18 2023	BUY Exercise of conversion of derivative security	-	8,733 Added 38.36%	14,033 Common Stock
Dec 13 2021	BUY Open market or private purchase	$32,064 $20.04 p/Share	1,600 Added 23.19%	5,300 Common Stock
May 11 2021	BUY Open market or private purchase	$27,400 $10.96 p/Share	2,500 Added 40.32%	3,700 Common Stock
Jan 29 2021	BUY Open market or private purchase	$19,236 $16.03 p/Share	1,200 Added 50.0%	1,200 Common Stock

Jill Leversage

Director

Victoria, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Value

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH

Account